12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Deals

MinoGuard Ltd., XTL deal

XTL will acquire neurology company MinoGuard for undisclosed milestones and royalties. MinoGuard's lead compound, SAM-101, recently...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >